Back to search

Article

Caspase recruiting domain-containing protein 11 (CARD11) serves as a therapeutic biomarker for the drug therapies of clear cell renal cell carcinoma

2023-12-06

Abstract excerpt

Clear cell renal cell carcinoma (ccRCC) belongs to the ten most diagnosed cancer types worldwide. Novel drug therapies are introduced and beneficial to the advanced ccRCC but lack effective biomarkers for the therapeutic response. Tumor-infiltrating immune cells and gene signatures are two critical factors for the response to immunotherapy and targeted therapy. Meanwhile, Caspase recruiting domain-containing prote...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
58d79b86-64cc-5b1f-a5d3-fee7cc7bf8fb
DOI
10.21203/rs.3.rs-3686428/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Caspase recruiting domain-containing protein 11 (CARD11) serves as a therapeutic biomarker for the drug therapies of clear cell renal cell carcinomaDOI 10.21203/rs.3.rs-3686428/v1
Select a neighboring publication to make it the new centre.